Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 29;23(21):13165.
doi: 10.3390/ijms232113165.

Microglial Extracellular Vesicles as Modulators of Brain Microenvironment in Glioma

Affiliations
Review

Microglial Extracellular Vesicles as Modulators of Brain Microenvironment in Glioma

Myriam Catalano et al. Int J Mol Sci. .

Abstract

Microglial cells represent the resident immune elements of the central nervous system, where they exert constant monitoring and contribute to preserving neuronal activity and function. In the context of glioblastoma (GBM), a common type of tumor originating in the brain, microglial cells deeply modify their phenotype, lose their homeostatic functions, invade the tumoral mass and support the growth and further invasion of the tumoral cells into the surrounding brain parenchyma. These modifications are, at least in part, induced by bidirectional communication among microglial and tumoral cells through the release of soluble molecules and extracellular vesicles (EVs). EVs produced by GBM and microglial cells transfer different kinds of biological information to receiving cells, deeply modifying their phenotype and activity and could represent important diagnostic markers and therapeutic targets. Recent evidence demonstrates that in GBM, microglial-derived EVs contribute to the immune suppression of the tumor microenvironment (TME), thus favoring GBM immune escape. In this review, we report the current knowledge on EV formation, biogenesis, cargo and functions, with a focus on the effects of microglia-derived EVs in GBM. What clearly emerges from this analysis is that we are at the beginning of a full understanding of the complete picture of the biological effects of microglial-derived EVs and that further investigations using multidisciplinary approaches are necessary to validate their use in GBM diagnosis and therapy.

Keywords: CNS; extracellular vesicles; glioma; immune evasion; microglia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Microglia-derived EVs in glioma.

References

    1. Ostrom Q.T., Cioffi G. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro-Oncology. 2020;22:1–96. doi: 10.1093/neuonc/noaa200. - DOI - PMC - PubMed
    1. Abbruzzese C., Padey B. Drug repurposing for the treatment of glioblastoma multiforme. JECCR. 2017;36:169. doi: 10.1186/s13046-017-0642-x. - DOI - PMC - PubMed
    1. Pelvig D.P., Pakkenberg H., Stark A.K., Pakkenberg B. Neocortical glial cell numbers in human brains. Neurobiol. Aging. 2008;29:1754–1762. doi: 10.1016/j.neurobiolaging.2007.04.013. - DOI - PubMed
    1. Ginhoux F., Lim S., Hoeffel G., Low D., Huber T. Origin and differentiation of microglia. Front. Cell Neurosci. 2013;7:45. doi: 10.3389/fncel.2013.00045. - DOI - PMC - PubMed
    1. Thion M.S., Ginhoux F., Garel S. Microglia and early brain development: An intimate journey. Science. 2018;362:185–189. doi: 10.1126/science.aat0474. - DOI - PubMed